PBM Drug Price Disclosure Could Result In $67 Billion Increase To Medicare Over 10 Years, PWC Study Finds
This article was originally published in The Pink Sheet Daily
Executive Summary
PricewaterhouseCoopers expands on the Congressional Budget Office's recently revised estimates on the cost of drug pricing and discount disclosure.